Table 1.
Traits | SNP | Ethnics | Chr | Position | Nearest gene | EA | EAF | BETA | SE | Sample size | P value | Study | Reference | Journal |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sedentary behaviours | rs26579 | Europeans | 5 | 87,985,295 | MEF2C-AS2 | G | 0.415 | 0.028 | 0.005 | 91,105 | 2.60 × 10− 09 | UK Biobank | Aiden Doherty et al.,201828 | Nat Commun |
Sedentary behaviours | rs25966 | Europeans | 5 | 106,822,908 | EFNA5 | G | 0.531 | 0.028 | 0.005 | 91,105 | 3.00 × 10− 09 | UK Biobank | Aiden Doherty et al.,201828 | Nat Commun |
Sedentary behaviours | rs6801032 | Europeans | 3 | 68,527,135 | LOC105377146 | A | 0.259 | 0.031 | 0.005 | 91,105 | 3.10 × 10−09 | UK Biobank | Aiden Doherty et al.,201828 | Nat Commun |
Sedentary behaviours | rs7779206 | Europeans | 7 | 71,723,883 | CALN1 | A | 0.558 | 0.028 | 0.005 | 91,105 | 4.20 × 10−09 | UK Biobank | Aiden Doherty et al.,201828 | Nat Commun |
MVPA | rs429358 | Europeans | 19 | 45,411,941 | APOE | T | 0.850 | −0.019 | 0.003 | 377,234 | 7.30 × 10−11 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
MVPA | rs7804463 | Europeans | 7 | 133,447,651 | EXOC4 | T | 0.530 | 0.013 | 0.002 | 377,234 | 4.10 × 10−10 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
MVPA | rs2854277 | Europeans | 6 | 32,628,084 | HLA-DQB1 | C | 0.920 | 0.027 | 0.005 | 377,234 | 1.40 × 10−08 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
MVPA | rs1379183 | Europeans | 7 | 50,237,784 | C7orf72/SPATA48 | C | 0.410 | −0.012 | 0.002 | 377,234 | 1.70 × 10−08 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
MVPA | rs3094622 | Europeans | 6 | 30,327,952 | RPP21 | A | 0.860 | 0.018 | 0.003 | 377,234 | 1.00 × 10−08 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
MVPA | rs149943 | Europeans | 6 | 28,002,388 | ZNF165 | G | 0.850 | 0.016 | 0.003 | 377,234 | 5.60 × 10−08 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
MVPA | rs2035562 | Europeans | 3 | 85,056,521 | CADM2 | A | 0.330 | −0.014 | 0.002 | 377,234 | 1.00 × 10−09 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
MVPA | rs7854466 | Europeans | 9 | 37,044,388 | PAX5 | T | 0.560 | −0.014 | 0.002 | 377,234 | 2.40 × 10−11 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
MVPA | rs1043595 | Europeans | 7 | 128,410,012 | CALU | G | 0.720 | 0.013 | 0.002 | 377,234 | 4.20 × 10−08 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
VPA | rs1248860 | Europeans | 3 | 85,015,779 | CADM2 | G | 0.480 | −0.051 | 0.007 | 261,055 | 5.30 × 10−15 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
VPA | rs2764261 | Europeans | 6 | 108,927,842 | FOXO3 | A | 0.370 | 0.030 | 0.005 | 261,055 | 5.30 × 10−08 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
VPA | rs13243553 | Europeans | 7 | 133,506,955 | EXOC4 | G | 0.610 | 0.039 | 0.007 | 261,055 | 2.40 × 10−09 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
VPA | rs3781411 | Europeans | 10 | 126,715,436 | CTBP2 | C | 0.880 | 0.058 | 0.009 | 261,055 | 1.00 × 10−10 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
VPA | rs328902 | Europeans | 7 | 35,020,843 | DPY19L1 | C | 0.690 | −0.041 | 0.006 | 261,055 | 1.30 × 10−10 | UK Biobank | Klimentidis YC et al.,201827 | Int J Obes (Lond) |
Sleep duration | rs1191685 | Europeans | 2 | 113,811,454 | PAX8 | C | 0.370 | 2.870 | 0.470 | 44,563 | 1.06 × 10−09 | CHARGE | Daniel J. Gottlieb et al,201529 | Mol Psychiatry |
Sleep duration | rs1823125 | Europeans | 2 | 113,806,882 | PAX8 | G | 0.260 | 3.010 | 0.500 | 45,281 | 1.71 × 10−08 | CHARGE | Daniel J. Gottlieb et al,201529 | Mol Psychiatry |
Sleep duration | rs1807282 | Europeans | 2 | 113,826,506 | PAX8 | T | 0.260 | 2.890 | 0.490 | 46,805 | 3.91 × 10−09 | CHARGE | Daniel J. Gottlieb et al,201529 | Mol Psychiatry |
Sleep duration | rs1964463 | Europeans | 2 | 113,785,491 | PAX8 | G | 0.250 | 2.840 | 0.500 | 45,281 | 1.07 × 10−08 | CHARGE | Daniel J. Gottlieb et al,201529 | Mol Psychiatry |
Sleep duration | rs4587207 | Europeans | 6 | 30,874,924 | IER3 | G | 0.800 | −3.140 | 0.560 | 46,807 | 2.02 × 10−08 | CHARGE | Daniel J. Gottlieb et al,201529 | Mol Psychiatry |
Sleep duration | rs4248149 | Europeans | 6 | 30,875,606 | IER3 | C | 0.800 | −3.080 | 0.560 | 46,810 | 3.95 × 10−08 | CHARGE | Daniel J. Gottlieb et al,201529 | Mol Psychiatry |
Sleep duration | rs2394403 | Europeans | 6 | 30,875,848 | IER3 | T | 0.800 | −3.070 | 0.560 | 46,811 | 4.39 × 10−08 | CHARGE | Daniel J. Gottlieb et al,201529 | Mol Psychiatry |
SNP single nucleotide polymorphism; Chr chromosome; EA effect allele; EAF effect allele frequency; SE standard error; MVPA moderate-to-vigorous physical activity; VPA vigorous physical activity; CHARGE the Cohorts for Heart and Aging Research in Genomic Epidemiology